You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Boehringer Ingelheim
Dow
McKesson
Johnson and Johnson

Last Updated: February 21, 2020

DrugPatentWatch Database Preview

Details for Patent: 7,119,202


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,119,202
Title:Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties
Abstract:Disclosed are compounds of the formula ##STR00001## wherein R.sub.1 is hydrogen or an acyl group having 1 to 16 carbon atoms; R.sub.2 is a purine or pyrimidine base or an analogue or derivative thereof; Z is O, S, S.dbd.O or SO.sub.2; and pharmaceutically acceptable derivatives thereof. Also described are processes for and intermediates of use in their preparation, pharmaceutical compositions containing these compounds, and the use of these compounds in the antiviral treatment of mammals.
Inventor(s): Belleau, legal representative; Pierrette (Montreal, CA), Nguyen Ba; Paul (La Prairie, CA), Belleau, deceased; Bernard (Montreal, CA)
Assignee: Glaxo Wellcome Inc. (Research Triangle Park, NC)
Application Number:08/468,362
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 7,119,202

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,119,202

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Hungary39 45/90Feb 07, 1990
90310335Feb 08, 1990

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Dow
Express Scripts
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.